Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinicius Tragante

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Blood|November 21, 2024
Understanding fibrinogen geneticsVinicius Tragante, Magnus K Magnusson
International Journal of Cardiology|June 3, 2018
Mendelian randomization: A powerful method to determine causality of biomarkers in diseasesVinicius Tragante, Folkert W Asselbergs
Frontiers in Cardiovascular Medicine|June 6, 2022
Editorial: Improving Early Detection and Risk Prediction in Heart FailureVinicius Tragante, Anna Pilbrow, Katrina Poppe
Genetic Epidemiology|April 12, 2014
The ENCODE project and perspectives on pathwaysVinicius Tragante, Jason H Moore, Folkert W Asselbergs
Frontiers in Cardiovascular Medicine|April 20, 2018
Integrative Bioinformatics Approaches for Identification of Drug Targets in HypertensionDaiane Hemerich, Jessica van Setten, Vinicius Tragante, et al.
Science Translational Medicine|December 1, 2021
Comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics"Hilma Hólm, Patrick Sulem, Vinicius Tragante, et al.
The New England Journal of Medicine|August 14, 2020
Mendelian Randomization Study of ACLY and Cardiovascular DiseaseHilma Hólm, Patrick Sulem, Anna Helgadóttir, et al.
Scientific Reports|March 2, 2023
Effect of tissue-grouped regulatory variants associated to type 2 diabetes in related secondary outcomesDaiane Hemerich, Roelof A J Smit, Michael Preuss, et al.
Human Genetics|March 7, 2016
Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic riskVinicius Tragante, Folkert W Asselbergs, Daniel I Swerdlow, et al.
Genetic Epidemiology|May 31, 2019
A comparison of two workflows for regulome and transcriptome-based prioritization of genetic variants associated with myocardial massElisabetta Manduchi, Daiane Hemerich, Jessica van Setten, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Blood|November 21, 2024
Understanding fibrinogen geneticsVinicius Tragante, Magnus K Magnusson
International Journal of Cardiology|June 3, 2018
Mendelian randomization: A powerful method to determine causality of biomarkers in diseasesVinicius Tragante, Folkert W Asselbergs
Frontiers in Cardiovascular Medicine|June 6, 2022
Editorial: Improving Early Detection and Risk Prediction in Heart FailureVinicius Tragante, Anna Pilbrow, Katrina Poppe
Genetic Epidemiology|April 12, 2014
The ENCODE project and perspectives on pathwaysVinicius Tragante, Jason H Moore, Folkert W Asselbergs
Frontiers in Cardiovascular Medicine|April 20, 2018
Integrative Bioinformatics Approaches for Identification of Drug Targets in HypertensionDaiane Hemerich, Jessica van Setten, Vinicius Tragante, et al.
Science Translational Medicine|December 1, 2021
Comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics"Hilma Hólm, Patrick Sulem, Vinicius Tragante, et al.
The New England Journal of Medicine|August 14, 2020
Mendelian Randomization Study of ACLY and Cardiovascular DiseaseHilma Hólm, Patrick Sulem, Anna Helgadóttir, et al.
Scientific Reports|March 2, 2023
Effect of tissue-grouped regulatory variants associated to type 2 diabetes in related secondary outcomesDaiane Hemerich, Roelof A J Smit, Michael Preuss, et al.
Human Genetics|March 7, 2016
Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic riskVinicius Tragante, Folkert W Asselbergs, Daniel I Swerdlow, et al.
Genetic Epidemiology|May 31, 2019
A comparison of two workflows for regulome and transcriptome-based prioritization of genetic variants associated with myocardial massElisabetta Manduchi, Daiane Hemerich, Jessica van Setten, et al.
Pageof 13